Vor Biopharma (VOR) Other Accumulated Expenses (2019 - 2026)
Vor Biopharma's Other Accumulated Expenses came in at $476,000 for Q3 2026, up 146.6% from $193,000 a year earlier and up 50.2% from the prior quarter.
Powered by 
Analysis
Vor Biopharma (VOR) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Vor Biopharma's Other Accumulated Expenses was $554,000, down 36.5% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of -22.0% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $872,000 in FY2024 (-17.7%), $1.06 million in FY2023 (+86.1%), $569,000 in FY2022 (-28.6%) and $797,000 in FY2021 (-58.6%).
- The five-year range for quarterly Other Accumulated Expenses is $141,000 (Q2 2025) to $2.95 million (Q1 2022).
- Year-over-year, Other Accumulated Expenses has increased for three consecutive quarters, with growth averaging 14.9% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2026 (growth of 146.6%), and the weakest in Q3 2024 (a decline of 87.0%).
- Business Quant data shows VOR's Other Accumulated Expenses at $317,000 (Q2 2026), $698,000 (Q1 2026) and $554,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vor Biopharma | 1.20 Bn | -692.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 476,000.00 |
| Jun 30, 2026 | 317,000.00 |
| Mar 31, 2026 | 698,000.00 |
| Dec 31, 2025 | 554,000.00 |
| Sep 30, 2025 | 193,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 656,000.00 |
| Dec 31, 2024 | 872,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Jun 30, 2024 | 665,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 473,000.00 |
| Mar 31, 2023 | 627,000.00 |
| Dec 31, 2022 | 569,000.00 |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | 797,000.00 |
API Access
Vor Biopharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "VOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();